Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury

Frontiers in Bioscience

Volumn 10, Issue 2, 2005, Pages 1835-1867

  Meldrum, Daniel R ^a   Wang, Meijing ^a   Tsai, Ben M ^a   Kher, Ajay ^a   Pitcher, Jeffrey M ^a   Brown, John W ^a   Meldrum, Kirstan K ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytokines; Estrogen; Gender; Heart; IL 1; IL 6; Injury; Ischemia; Myocardium; Review; Sex Hormones; Testosterone; TNF

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SEX HORMONE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

BLEEDING; BURN; CELLULAR DISTRIBUTION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; INJURY; MYOCARDITIS; NONHUMAN; REVIEW; SEPSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

EID: 17244367718     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1665     Document Type: Review

References (373)

1. Wang M, L Baker, BM Tsai, KK Meldrum, and DR Meldrum: Sex Differences in the Myocardial Inflammatory Response to Ischemia/Reperfusion Injury. Am J Physiol Endocrinol Metab 288, E321-E326 (2005)
2. Wang M, BM Tsai, A Kher, LB Baker, GM Wairiuko, and DR Meldrum: The Role of Endogenous Testosterone in Myocardial Proinflammatory and Proapoptotic Signaling after Acute Ischemia-Reperfusion. Am J Physiol Heart Circ Physiol 288, H221-H226 (2005)
3. Pitcher JM, BM Tsai, M Wang, RD Nagy, and DR Meldrum: Is the preconditioning threshold higher in females? J Surg Res In press (2004)
4. Mendelsohn ME and RH Karas: The protective effects of estrogen on the cardiovascular system. N Engl J Med 340, 1801-1811 (1999)
5. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 274, R577-595 (1998)
6. Meldrum DR: Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil Steril 78, 1170-1171 (2002)
7. Meldrum DR, A Ayala, and IH Chaudry: Energetics of defective macrophage antigen presentation following hemorrhage. Surgery 112, 150-158 (1992)
8. Meldrum DR, A Ayala, and IH Chaudry: Mechanism of diltiazem's immunomodulatory effects following hemorrhage and resuscitation. Am J Physiol 265, C412-C421 (1993)
9. 2 restores energetics and decreases lethality. J Surg Res 57, 55-61 (1994)
10. Meldrum DR, A Ayala, MM Perrin, W Ertel, and IH Chaudry: Diltiazem restores IL-2, IL-3, IL-6, and IFN-gamma synthesis and decreases host susceptibility to sepsis following hemorrhage. J Surg Res 51, 158-164 (1991)
11. Meldrum DR, A Ayala, P Wang, W Ertel, and IH Chaudry: Association between decreased splenic ATP levels and immunodepression: amelioration with ATP-MgC12. Am J Physiol 261, R351-357 (1991)
12. Meldrum DR, BS Cain, JC Cleveland, Jr., X Meng, A Ayala, A Banerjee, and AH Harken: Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92, 472-477 (1997)
13. 1-adrenoceptor mediated, protein synthesis independent mechanism. Am J Physiol 272, R718-R725 (1997)
14. Meldrum DR, JC Cleveland, MB Mitchell, RT Rowland, A Banerjee, and AH Harken: Constructive priming of myocardium against ischemia-reperfusion injury. Shock 6, 238-242 (1996)
15. 2+ induced cardioadaptation to ischemia-reperfusion injury. Am J Physiol 271, R1718-R1726 (1996)
16. Meldrum DR, JC Cleveland, EE Moore, DA Partrick, A Banerjee, and AH Harken: Adaptive and maladaptive mechanisms of cellular priming. Ann Surg 226, 587-598. (1997)
17. Meldrum DR, JC Cleveland, RT Rowland, A Banerjee, and AH Harken: Calcium induced inotropy is in part mediated by protein kinase C. J Surg Res 63, 400-405 (1996)
18. Meldrum DR, JC Cleveland, RT Rowland, A Banerjee, AH Harken, and X Meng: Early and delayed preconditioning: Differential mechanisms and additive protection. Am J Physiol 273, H725-H733 (1997)
19. Meldrum DR, JC Cleveland, BC Sheridan, X Meng, F Robertson, BS Cain, AH Harken, and A Banerjee: Protein kinase C isoform diversity in preconditioning. J Surg Res 69, 183-187 (1997)
20. Meldrum DR, JC Cleveland, BC Sheridan, RT Rowland, A Banerjee, and AH Harken: Differential effects of adenosine preconditioning on the post-ischemic rat myocardium. J Surg Res 65, 156-164 (1996)
21. Meldrum DR, JC Cleveland, BC Sheridan, RT Rowland, A Banerjee, and AH Harken; Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 61, 1273-1280 (1996)
22. Meldrum DR, JC Cleveland, BC Sheridan, RT Rowland, A Banerjee, and AH Harken: Cardiac preconditioning with calcium: Clinically accessible myocardial protection. J Thorac Cardiovasc Surg 112, 778-786 (1996)
23. Meldrum DR, JC Cleveland, BC Sheridan, RT Rowland, CH Selzman, A Banerjee, and AH Harken: Alpha-adrenergic activation of myocardial NFκB during hemorrhage. J Surg Res 69, 268-276 (1997)
24. Meldrum DR, CA Dinarello, JC Cleveland, Jr., BS Cain, BD Shames, X Meng, and AH Harken: Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. Surgery 124, 291-296; discussion 297 (1998)
25. Meldrum DR, CA Dinarello, JC Cleveland, BS Cain, BD Shames, X Meng, and AH Harken: Ischemic preconditioning decreases post-ischemic myocardial TNF: Potential ultimate effector mechanism of preconditioning. Circulation 98, 214-219 (1998)
26. Meldrum DR, CA Dinarello, JC Cleveland, BS Cain, BD Shames, X Meng, and AH Harken: Feature Article. Human myocardial TNF production following acute global ischemia and reperfusion injury in vivo. J Mol Cell Cardiol 30, 1683-1689 (1998)
27. Meldrum DR, CA Dinarello, JC Cleveland, L Shapiro, BC Sheridan, and AH Harken: p38 MAP kinase mediates myocardial ischemia reperfusion injury. Surg Forum In press (1997)
28. Meldrum DR, CA Dinarello, BD Shames, JC Cleveland, Jr., BS Cain, A Banerjee, X Meng, and AH Harken: Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production. Potential ultimate effector mechanism of preconditioning. Circulation 98, II214-218; discussion II218-219 (1998)
29. Meldrum DR and KK Donnahoo: Role of TNF in mediating renal insufficiency following cardiac surgery: evidence of a postbypass cardiorenal syndrome. J Surg Res 85, 185-199 (1999)
30. Meldrum DR, RC McIntyre, BC Sheridan, JC Cleveland, Jr., DA Fullerton, and AH Harken: L-arginine decreases alveolar macrophage proinflammatory monokine production during acute lung injury by a nitric oxide synthase-dependent mechanism. J Trauma 43, 888-893 (1997)
31. Meldrum DR, X Meng, CA Dinarello, A Ayala, BS Cain, BD Shames, L Ao, A Banerjee, and AH Harken: Human myocardial tissue TNFalpha expression following acute global ischemia in vivo. J Mol Cell Cardiol 30, 1683-1689 (1998)
32. Meldrum DR, X Meng, BD Shames, B Pomerantz, KK Donnahoo, A Banerjee, and AH Harken: Liposomal delivery of heat-shock protein 72 into the heart prevents endotoxin-induced myocardial contractile dysfunction. Surgery 126, 135-141 (1999)
33. Meldrum DR, X Meng, BC Sheridan, RC McIntyre, Jr., AH Harken, and A Banerjee: Tissue-specific protein kinase C isoforms differentially mediate macrophage TNFalpha and IL-1beta production. Shock 9, 256-260 (1998)
34. Meldrum DR, MB Mitchell, A Banerjee, and AH Harken: Cardiac preconditioning: Induction of endogenous tolerance to ischemia-reperfusion injury. Arch Surg 128, 1208-1211 (1993)
35. Meldrum DR, DA Partrick, JC Cleveland, Jr., R Shenkar, KK Meldrum, A Raiesdana, A Ayala, JW Brown, and AH Harken: On-pump coronary artery bypass surgery activates human myocardial NF-kappaB and increases TNF-alpha in the heart. J Surg Res 112, 175-179 (2003)
36. Meldrum DR, R Shenkar, BC Sheridan, BS Cain, E Abraham, and AH Harken: Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol 29, 2849-2854 (1997)
37. Meldrum DR, BC Sheridan, JC Cleveland, DA Fullerton, A Banerjee, and AH Harken: Neutrophils are required for endotoxin induced myocardial cross-tolerance to ischemia-reperfusion injury. Arch Surg 131, 1203-1208 (1996)
38. Meldrum KK, DR Meldrum, KL Hile, EB Yerkes, A Ayala, MP Cain, RC Rink, AJ Casale, and MA Kaefer: p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 281, C563-570 (2001)
39. Meldrum KK, DR Meldrum, X Meng, L Ao, and AH Harken: TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am J Physiol Heart Circ Physiol 282, H540-546 (2002)
40. Meldrum KK, DR Meldrum, SF Sezen, JK Crone, and AL Burnett: Heat shock prevents simulated ischemia-induced apoptosis in renal tubular cells via a PKC-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 281, R359-364 (2001)
41. Meldrum DR: Tech. Sight. Sequencing genomes and beyond. Science 292, 515-517 (2001)
42. Meldrum KK, AL Burnett, X Meng, R Misseri, MB Shaw, JP Gearhart, and DR Meldrum: Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 92, 293-299 (2003)
43. Ansar Ahmed S, WJ Penhale, and N Talal: Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121, 531-551 (1985)
44. Rossouw JE: Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 53, 550-557 (2002)
45. Kapadia S, J Lee, G Torre-Amione, HH Birdsall, TS Ma, and DL Mann: Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96, 1042-1052 (1995)
46. Kumar A, V Thota, L Dee, J Olson, E Uretz, and JE Parrilio: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183, 949-958 (1996)
47. Maass DL, J White, and JW Horton: IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac contractile function after burn trauma. Shock 18, 360-366 (2002)
48. Cain BS, DR Meldrum, CA Dinarello, X Meng, KS Joo, A Banerjee, and AH Harken: Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function. Crit Care Med 27, 1309-1318 (1999)
49. Tracey KJ, Y Fong, DG Hesse, KR Manogue, AT Lee, GC Kuo, SF Lowry, and A Cerami: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664 (1987)
50. Sakamoto A, J Matsumura, S Mii, Y Gotoh, and R Ogawa: A prostaglandin E2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production. Shock 22, 76-81 (2004)
51. Arumugam TV, IA Shiels, TM Woodruff, DN Granger, and SM Taylor: The role of the complement system in ischemia-reperfusion injury. Shock 21, 401-409 (2004)
52. Angele MK, MG Schwacha, A Ayala, and IH Chaudry: Effect of gender and sex hormones on immune responses following shock. Shock 14, 81-90 (2000)
53. Baker L, KK Meldrum, M Wang, R Sankula, R Vanam, A Raiesdana, B Tsai, K Hile, JW Brown, and DR Meldrum: The role of estrogen in cardiovascular disease. J Surg Res 115, 325-344 (2003)
54. Becker RC, M Terrin, R Ross, GL Knatterud, P Desvigne-Nickens, JM Gore, and E Braunwald: Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med 120, 638-645 (1994)
55. Kostis JB, AC Wilson, K O'Dowd, P Gregory, S Chelton, NM Cosgrove, A Chirala, and T Cui: Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS Study Group. Myocardial Infarction Data Acquisition System. Circulation 90, 1715-1730 (1994)
56. Demirovic J, H Blackburn, PG McGovern, R Luepker, JM Sprafka, and D Gilbertson: Sex differences in early mortality after acute myocardial infarction (the Minnesota Heart Survey) Am J Cardiol 75, 1096-1101 (1995)
57. Vaccarino V, HM Krumholz, LF Berkman, and RI Horwitz: Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 91, 1861-1871 (1995)
58. Sonke GS, R Beaglehole, AW Stewart, R Jackson, and FM Stewart: Sex differences in case fatality before and after admission to hospital after acute cardiac events: analysis of community based coronary heart disease register. BMJ 313, 853-855 (1996)
59. Tunstall-Pedoe H, C Morrison, M Woodward, B Fitzpatrick, and G Watt: Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 93, 1981-1992 (1996)
60. Chambless L, U Keil, A Dobson, M Mahonen, K Kuulasmaa, AM Rajakangas, H Lowel, and H Tunstall-Pedoe: Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation 96, 3849-3859 (1997)
61. Napolitano LM, ME Greco, A Rodriguez, JA Kufera, RS West, and TM Scalea: Gender differences in adverse outcomes after blunt trauma. J Trauma 50, 274-280 (2001)
62. Oberholzer A, M Keel, R Zellweger, U Steckholzer, O Trentz, and W Ertel: Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 48, 932-937 (2000)
63. Gannon CJ, LM Napolitano, M Pasquale, JK Tracy, and RJ McCarter: A statewide population-based study of gender differences in trauma: validation of a prior single-institution study. J Am Coll Surg 195, 11-18 (2002)
64. rd: The association between gender and mortality among trauma patients as modified by age. J Trauma 54, 464-471 (2003)
65. Wohltmann CD, GA Franklin, PW Boaz, FA Luchette, PA Kearney, JD Richardson, and DA Spain: A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg 181, 297-300 (2001)
66. Mostafa G, T Huynh, RF Sing, WS Miles, HJ Norton, and MH Thomason: Gender-related outcomes in trauma. J Trauma 53, 430-434; discussion 434-435 (2002)
67. Offner PJ, EE Moore, and WL Biffl: Male gender is a risk factor for major infections after surgery. Arch Surg 134, 935-938; discussion 938-940 (1999)
68. Gannon CJ, M Pasquale, JK Tracy, RJ McCarter, and LM Napolitano: Male gender is associated with increased risk for postinjury pneumonia. Shock 21, 410-414 (2004)
69. Eachempati SR, L Hydo, and PS Barie: Gender-based differences in outcome in patients with sepsis. Arch Surg 134, 1342-1347 (1999)
70. Schroder J, V Kahlke, M Book, and F Stuber: Gender differences in sepsis: genetically determined? Shock 14, 307-310; discussion 310-303 (2000)
71. Schroder J, V Kahlke, KH Staubach, P Zabel, and F Stuber: Gender differences in human sepsis. Arch Surg 133, 1200-1205 (1998)
72. Wichmann MW, D Inthorn, HJ Andress, and FW Schildberg: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26, 167-172 (2000)
73. Muller MJ, SP Pegg, and MR Rule: Determinants of death following burn injury. Br J Surg 88, 583-587 (2001)
74. O'Keefe GE, JL Hunt, and GF Purdue: An evaluation of risk factors for mortality after burn trauma and the identification of gender-dependent differences in outcomes. J Am Coll Surg 192, 153-160 (2001)
75. Gumming J, GF Purdue, JL Hunt, and GE O'Keefe: Objective estimates of the incidence and consequences of multiple organ dysfunction and sepsis after burn trauma. J Trauma 50, 510-515 (2001)
76. Delyani JA, T Murohara, TO Nossuli, and AM Lefer: Protection from myocardial reperfusion injury by acute administration of 17 beta-estradiol. J Mol Cell Cardiol 28, 1001-1008 (1996)
77. Booth EA, M Marchesi, EJ Kilbourne, and BR Lucchesi: 17Beta-estradiol as a receptor-mediated cardioprotective agent. J Pharmacol Exp Ther 307, 395-401 (2003)
78. Node K, M Kitakaze, H Kosaka, T Minamino, H Funaya, and M Hori: Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels. Circulation 96, 1953-1963 (1997)
79. Hale SL, Y Birnbaum, and RA Kloner: beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J 132, 258-262 (1996)
80. Kolodgie FD, A Farb, SH Litovsky, J Narula, LA Jeffers, SJ Lee, and R Virmani: Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol 29, 2403-2414 (1997)
81. Kim YD, B Chen, J Beauregard, P Kouretas, G Thomas, MY Farhat, AK Myers, and DE Lees: 17 beta-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 94, 2901-2908 (1996)
82. McHugh NA, SM Cook, JL Schairer, MM Bidgoli, and GF Merrill: Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am J Physiol 268, H2569-2573 (1995)
83. Beer S, M Reincke, M Kral, SZ Lie, S Steinhauer, HH Schmidt, B Allolio, and S Neubauer: Susceptibility to cardiac ischemia/reperfusion injury is modulated by chronic estrogen status. J Cardiovasc Pharmacol 40, 420-428 (2002)
84. Zhai P, TE Eurell, R Cotthaus, EH Jeffery, JM Bahr, and DR Gross: Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am J Physiol Heart Circ Physiol 279, H2766-2775 (2000)
85. Horton JW, DJ White, and DL Maass: Gender-related differences in myocardial inflammatory and contractile responses to major burn trauma. Am J Physiol Heart Circ Physiol 286, H202-213 (2004)
86. Wichmann MW, R Zellweger, CM DeMaso, A Ayala, and IH Chaudry: Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine 8, 853-863 (1996)
87. Angele MK, MW Knoferl, MG Schwacha, A Ayala, WG Cioffi, KI Bland, and IH Chaudry: Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol 277, C35-42 (1999)
88. Zellweger R, MW Wichmann, A Ayala, S Stein, CM DeMaso, and IH Chaudry: Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25, 106-110 (1997)
89. Angele MK, A Ayala, WG Cioffi, KI Bland, and IH Chaudry: Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. Am J Physiol 274, C1530-1536 (1998)
90. Angele MK, A Ayala, BA Monfils, WG Cioffi, KI Bland, and IH Chaudry: Testosterone and/or low estradiol: normally required but harmful immunologically for males after trauma-hemorrhage. J Trauma 44, 78-85 (1998)
91. Messingham KA, M Shirazi, LA Duffner, MA Emanuele, and EJ Kovacs: Testosterone receptor blockade restores cellular immunity in male mice after burn injury. J Endocrinol 169, 299-308 (2001)
92. Ba ZF, P Wang, DJ Koo, M Zhou, WG Cioffi, KI Bland, and IH Chaudry: Testosterone receptor blockade after trauma and hemorrhage attenuates depressed adrenal function. Am J Physiol Regul Integr Comp Physiol 279, R1841-1848 (2000)
93. Remmers DE, P Wang, WG Cioffi, KI Bland, and IH Chaudry: Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol 273, H2919-2925 (1997)
94. Angele MK, MW Wichmann, A Ayala, WG Cioffi, and IH Chaudry: Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg 132, 1207-1214 (1997)
95. Knoferl MW, MK Angele, MG Schwacha, TS Anantha Samy, KI Bland, and IH Chaudry: Immunoprotection in proestrus females following trauma-hemorrhage: the pivotal role of estrogen receptors. Cell Immunol 222, 27-34 (2003)
96. Knoferl MW, MK Angele, MD Diodato, MG Schwacha, A Ayala, WG Cioffi, KI Bland, and IH Chaudry: Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg 235, 105-112 (2002)
97. Jarrar D, P Wang, WG Cioffi, KI Bland, and IH Chaudry: The female reproductive cycle is an important variable in the response to trauma-hemorrhage. Am J Physiol Heart Circ Physiol 279, H1015-1021 (2000)
98. Lloyd GW, NR Patel, E McGing, AF Cooper, D Brennand-Roper, and G Jackson: Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart 84, 189-192 (2000)
99. Kawano H, T Motoyama, M Ohgushi, K Kugiyama, H Ogawa, and H Yasue: Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 135, 977-981 (2001)
100. Clark PI, SP Glasser, GH Lyman, J Krug-Fite, and A Root: Relation of results of exercise stress tests in young women to phases of the menstrual cycle. Am J Cardiol 61, 197-199 (1988)
101. Durant R, K Klouche, S Delbosc, M Morena, L Amigues, JJ Beraud, B Canaud, and JP Cristol: Superoxide anion overproduction in sepsis: effects of vitamin E and simvastatin. Shock 22, 34-39 (2004)
102. Huot J, F Houle, F Marceau, and J Landry: Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80, 383-392 (1997)
103. Guyton KZ, Y Liu, M Gorospe, Q Xu, and NJ Holbrook: Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271, 4138-4142 (1996)
104. Mihm S, D Galter, and W Droge: Modulation of transcription factor NF kappa B activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. Faseb J 9, 246-252 (1995)
105. Liu SL, S Degli Esposti, T Yao, AM Diehl, and MA Zern: Vitamin E therapy of acute CC14-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 22, 1474-1481 (1995)
106. Ballard-Croft C, DJ White, DL Maass, DP Hybki, and JW Horton: Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-alpha. Am J Physiol Heart Circ Physiol 280, H1970-1981 (2001)
107. Cain BS, DR Meldrum, X Meng, CA Dinarello, BD Shames, A Banerjee, and AH Harken: p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function. J Surg Res 83, 7-12 (1999)
108. Wang M, R Sankula, BM Tsai, KK Meldrum, M Turrentine, KL March, JW Brown, CA Dinarello, and DR Meldrum: P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Shock 21, 170-174 (2004)
109. Kita T, H Yamaguchi, H Sato, K Kasai, T Tanaka, and N Tanaka: Role of p38 mitogen-activated protein kinase pathway on renal failure in the infant rat after burn injury. Shock 21, 535-542 (2004)
110. Lub-De Hooge MN, S De Jong, C Vermot-Desroches, JE Tulleken, EG De Vries, and JG Zijlstra: Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway. Shock 22, 186-188 (2004)
111. Lee JC, JT Laydon, PC McDonnell, TF Gallagher, S Kumar, D Green, D McNulty, MJ Blumenthal, JR Heys, SW Landvatter, and et al: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746 (1994)
112. Schafer PH, SA Wadsworth, L Wang, and JJ Siekierka: p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells. J Immunol 162, 7110-7119 (1999)
113. Beyaert R, A Cuenda, W Vanden Berghe, S Plaisance, JC Lee, G Haegeman, P Cohen, and W Fiers: The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. Embo J 15, 1914-1923 (1996)
114. Marie C, S Roman-Roman, and G Rawadi: Involvement of mitogen-activated protein kinase pathways in interleukin-8 production by human monocytes and polymorphonuclear cells stimulated with lipopolysaccharide or Mycoplasma fermentans membrane lipoproteins. Infect Immun 67, 688-693 (1999)
115. Zechner D, R Craig, DS Hanford, PM McDonough, RA Sabbadini, and CC Glembotski: MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem 273, 8232-8239 (1998)
116. Brown MA and WK Jones: NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci 9, 1201-1217 (2004)
117. Carter AB, KL Knudtson, MM Monick, and GW Hunninghake: The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP) J Biol Chem 274, 30858-30863 (1999)
118. Nick JA, NJ Avdi, SK Young, LA Lehman, PP McDonald, SC Frasch, MA Billstrom, PM Henson, GL Johnson, and GS Worthen: Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103, 851-858 (1999)
119. Maass DL, DP Hybki, J White, and JW Horton: The time course of cardiac NF-kappaB activation and TNF-alpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction. Shock 17, 293-299 (2002)
120. Lum RT, SS Kerwar, SM Meyer, MG Nelson, SR Schow, D Shiffman, MM Wick, and A Joly: A new structural class of proteasome inhibitors that prevent NF-kappa B activation. Biochem Pharmacol 55, 1391-1397 (1998)
121. Wesche H, WJ Henzel, W Shillinglaw, S Li, and Z Cao: MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837-847 (1997)
122. Burns K, F Martinen, C Esslinger, H Pahl, P Schneider, JL Bodmer, F Di Marco, L French, and J Tschopp: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273, 12203-12209 (1998)
123. Wang C, L Deng, M Hong, GR Akkaraju, J Inoue, and ZJ Chen: TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001)
124. Levy RJ and CS Deutschman: Evaluating myocardial depression in sepsis. Shock 22, 1-10 (2004)
125. Krown KA, K Yasui, MJ Brooker, AE Dubin, C Nguyen, GL Harris, PM McDonough, CC Glembotski, PT Palade, and RA Sabbadini: TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients. FEBS Lett 376, 24-30 (1995)
126. Yokoyama T, L Vaca, RD Rossen, W Durante, P Hazarika, and DL Mann: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92, 2303-2312 (1993)
127. Oral H, GW Dorn, 2nd, and DL Mann: Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem 272, 4836-4842 (1997)
128. Goldhaber JI, KH Kim, PD Natterson, T Lawrence, P Yang, and JN Weiss: Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes. Am J Physiol 271, H1449-1455 (1996)
129. Finkel MS, CV Oddis, TD Jacob, SC Watkins, BG Harder, and RL Simmons: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257, 387-389 (1992)
130. Kurrelmeyer KM, LH Michael, G Baumgarten, GE Taffet, JJ Peschon, N Sivasubramanian, ML Entman, and DL Mann: Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97, 5456-5461 (2000)
131. Reinhart K, C Wiegand-Lohnert, F Grimminger, M Kaul, S Withington, D Treacher, J Eckart, S Willatts, C Bouza, D Krausch, F Stockenhuber, J Eiselstein, L Daum, and J Kempeni: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 24, 733-742 (1996)
132. Wertheimer SJ, CL Myers, RW Wallace, and TP Parks: Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate. J Biol Chem 267, 12030-12035 (1992)
133. Youker K, CW Smith, DC Anderson, D Miller, LH Michael, RD Rossen, and ML Entman: Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 89, 602-609 (1992)
134. Kukielka GL, CW Smith, AM Manning, KA Youker, LH Michael, and ML Entman: Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92, 1866-1875 (1995)
135. Entman ML, K Youker, T Shoji, G Kukielka, SB Shappell, AA Taylor, and CW Smith: Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90, 1335-1345 (1992)
136. Romson JL, BG Hook, SL Kunkel, GD Abrams, MA Schork, and BR Lucchesi: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67, 1016-1023 (1983)
137. Jolly SR, WJ Kane, BG Hook, GD Abrams, SL Kunkel, and BR Lucchesi: Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J 112, 682-690 (1986)
138. Litt MR, RW Jeremy, HF Weisman, JA Winkelstein, and LC Becker: Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 80, 1816-1827 (1989)
139. Granger DN: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 255, H1269-1275 (1988)
140. Patel KD, GA Zimmerman, SM Prescott, RP McEver, and TM McIntyre: Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 112, 749-759 (1991)
141. Shingu M and M Nobunaga: Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide. Am J Pathol 117, 201-206 (1984)
142. Akgur FM, MF Brown, GB Zibari, JC McDonald, CJ Epstein, CR Ross, and DN Granger: Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol 279, H791-797 (2000)
143. Lakshminarayanan V, DW Beno, RH Costa, and KA Roebuck: Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-alpha in endothelial and epithelial cells. J Biol Chem 272, 32910-32918 (1997)
144. Sellak H, E Franzini, J Hakim, and C Pasquier: Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 83, 2669-2677 (1994)
145. Jolly SR, WJ Kane, MB Bailie, GD Abrams, and BR Lucchesi: Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 54, 277-285 (1984)
146. Wang P, H Chen, H Qin, S Sankarapandi, MW Becher, PC Wong, and JL Zweier: Overexpression of human copper, zinc-superoxide dismutase (SOD1) prevents postischemic injury. Proc Natl Acad Sci U S A 95, 4556-4560 (1998)
147. Chen Z, B Siu, YS Ho, R Vincent, CC Chua, RC Hamdy, and BH Chua: Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30, 2281-2289 (1998)
148. Flaherty JT, B Pitt, JW Gruber, RR Heuser, DA Rothbaum, LR Burwell, BS George, DJ Kereiakes, D Deitchman, N Gustafson, and et al: Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 89, 1982-1991 (1994)
149. Murohara Y, Y Yui, R Hattori, and C Kawai: Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction. Am J Cardiol 67, 765-767 (1991)
150. Kim NG, H Lee, E Son, OY Kwon, JY Park, JH Park, GJ Cho, WS Choi, and K Suk: Hypoxic induction of caspase-11/caspase-1/interleukin-1beta in brain microglia. Brain Res Mol Brain Res 114, 107-114 (2003)
151. Hur J, SY Kim, H Kim, S Cha, MS Lee, and K Suk: Induction of caspase-11 by inflammatory stimuli in rat astrocytes: lipopolysaccharide induction through
152. Deshpande R, H Khalili, RG Pergolizzi, SD Michael, and MD Chang: Estradiol down-regulates LPS-induced cytokine production and NFκB activation in murine macrophages. Am J Reprod Immunol 38, 46-54 (1997)
153. Mizushima Y, P Wang, D Jarrar, WG Cioffi, KI Bland, and IH Chaudry: Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann Surg 232, 673-679 (2000)
154. Wang M, B Tsai, JW Brown, and DR Meldrum: Gender differences in myocardial apoptotic signaling and recovery following acute injury. Shock 21(Suppl 2), 23 (2004)
155. Angele MK, S Nitsch, MW Knoferl, A Ayala, P Angele, FW Schildberg, KW Jauch, and IH Chaudry: Sex-specific p38 MAP kinase activation following trauma-hemorrhage: involvement of testosterone and estradiol. Am J Physiol Endocrinol Metab 285, E189-196 (2003)
156. McHugh NA, GF Merrill, and SR Powell: Estrogen diminishes postischemic hydroxyl radical production. Am J Physiol 274, H1950-1954 (1998)
157. Kim YD, MY Farhat, AK Myers, P Kouretas, KW DeGroot, A Pacquing, PW Ramwell, JP Suyderhoud, and DE Lees: 17-Beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs. J Cardiovasc Pharmacol 32, 457-465 (1998)
158. Barp J, AS Araujo, TR Fernandes, KV Rigatto, S Llesuy, A Bello-Klein, and P Singal: Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz J Med Biol Res 35, 1075-1081 (2002)
159. Squadrito F, D Altavilla, G Squadrito, GM Campo, M Arlotta, V Arcoraci, L Minutoli, M Serrano, A Saitta, and AP Caputi: 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol 335, 185-192 (1997)
160. Sumeray MS, DD Rees, and DM Yellon: Infarct size and nitric oxide synthase in murine myocardium. J Mol Cell Cardiol 32, 35-42 (2000)
161. Xi L, NC Jarrett, ML Hess, and RC Kukreja: Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation 99, 2157-2163 (1999)
162. Weiner CP, I Lizasoain, SA Baylis, RG Knowles, IG Charles, and S Moncada: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 91, 5212-5216 (1994)
163. Nuedling S, S Kahlert, K Loebbert, PA Doevendans, R Meyer, H Vetter, and C Grohe: 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 43, 666-674 (1999)
164. Kleinert H, T Wallerath, C Euchenhofer, I Ihrig-Biedert, H Li, and U Forstermann: Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31, 582-588 (1998)
165. Grohe C, S Kahlert, K Lobbert, and H Vetter: Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol 156, R1-7 (1998)
166. Ma XL, AS Weyrich, DJ Lefer, and AM Lefer: Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72, 403-412 (1993)
167. Lefer AM and DJ Lefer: The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32, 743-751 (1996)
168. Hoshida S, N Yamashita, J Igarashi, M Nishida, M Hori, T Kamada, T Kuzuya, and M Tada: Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J Pharmacol Exp Ther 274, 413-418 (1995)
169. Steenbergen C, E Murphy, JA Watts, and RE London: Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 66, 135-146 (1990)
170. Marban E, Y Koretsune, M Corretti, VP Chacko, and H Kusuoka: Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation 80, IV17-22 (1989)
171. Quignard JF, JM Frapier, MC Harricane, B Albat, J Nargeot, and S Richard: Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide. J Clin Invest 99, 185-193 (1997)
172. Mery PF, C Pavoine, L Belhassen, F Pecker, and R Fischmeister: Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268, 26286-26295 (1993)
173. Zahradnikova A and O Krizanova: Nitric oxide and its effects on the calcium transport systems in the myocardium. Gen Physiol Biophys 16, 197-214 (1997)
174. Zahradnikova A, I Minarovic, RC Venema, and LG Meszaros: Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 22, 447-454 (1997)
175. Ziolo MT, H Katoh, and DM Bers: Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes. Circulation 104, 2961-2966 (2001)
176. Shinbo A and T lijima: Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channel openers in guinea-pig ventricular cells. Br J Pharmacol 120, 1568-1574 (1997)
177. Sasaki N, T Sato, A Ohler, B O'Rourke, and E Marban: Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101, 439-445 (2000)
178. Kim HW, NA Steenaart, DG Ferguson, and EG Kranias: Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2(+)-ATPase with phospholamban in phospholipid vesicles. J Biol Chem 265, 1702-1709 (1990)
179. Kranias EG: Regulation of Ca2+ transport by cyclic 3′,5′-AMP- dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. Biochim Biophys Acta 844, 193-199 (1985)
180. Lindemann JP, LR Jones, DR Hathaway, BG Henry, and AM Watanabe: beta-Adrenergic stimulation of phospholamban phosphorylation and Ca2+-ATPase activity in guinea pig ventricles. J Biol Chem 258, 464-471 (1983)
181. Wu G, SL Yang, C Hsu, RC Yang, HK Hsu, N Liu, J Yang, LW Dong, and MS Liu: Transcriptional regulation of cardiac sarcoplasmic reticulum calcium-ATPase gene during the progression of sepsis. Shock 22, 46-50 (2004)
182. Golden KL, QI Fan, B Chen, J Ren, J O'Connor, and JD Marsh: Adrenergic stimulation regulates Na(+)/Ca(2+)Exchanger expression in rat cardiac myocytes. J Mol Cell Cardiol 32, 611-620 (2000)
183. Thawornkaiwong A, S Preawnim, and J Wattanapermpool: Upregulation of beta 1-adrenergic receptors in ovariectomized rat hearts. Life Sci 72, 1813-1824 (2003)
184. Kam KW, JS Qi, M Chen, and TM Wong: Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther 309, 8-15 (2004)
185. Cross HR, EG Kranias, E Murphy, and C Steenbergen: Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am J Physiol Heart Circ Physiol 284, H683-690 (2003)
186. Cross HR, E Murphy, and C Steenbergen: Ca(2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 283, H481-489 (2002)
187. Golden KL, JD Marsh, and Y Jiang: Castration reduces mRNA levels for calcium regulatory proteins in rat heart Endocrine 19, 339-344 (2002)
188. Tani M and JR Neely: Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res 65, 1045-1056 (1989)
189. Murphy E, M Perlman, RE London, and C Steenbergen: Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 68, 1250-1258 (1991)
190. Murphy E, HR Cross, and C Steenbergen: Is Na/Ca exchange during ischemia and reperfusion beneficial or detrimental? Ann N Y Acad Sci 976, 421-430 (2002)
191. Cross HR, L Lu, C Steenbergen, KD Philipson, and E Murphy: Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83, 1215-1223 (1998)
192. Sugishita K, Z Su, F Li, KD Philipson, and WH Barry: Gender influences [Ca(2+)](i) during metabolic inhibition in myocytes overexpressing the Na(+)-Ca(2+) exchanger. Circulation 104, 2101-2106 (2001)
193. Cleveland JC, Jr., DR Meldrum, RT Rowland, A Banerjee, and AH Harken: Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel. J Mol Cell Cardiol 29, 175-182 (1997)
194. Downey JM and MV Cohen: Signal transduction in ischemic preconditioning. Adv Exp Med Biol 430, 39-55 (1997)
195. Light PE, AA Sabir, BG Allen, MP Walsh, and RJ French: Protein kinase C-induced changes in the stoichiometry of ATP binding activate cardiac ATP-sensitive K+ channels. A possible mechanistic link to ischemic preconditioning. Circ Res 79, 399-406 (1996)
196. Miyamae M, SA Camacho, MW Weiner, and VM Figueredo: Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts. Am J Physiol 271, H2145-2153 (1996)
197. Delcamp TJ, C Dales, L Ralenkotter, PS Cole, and RW Hadley: Intramitochondrial [Ca2+] and membrane potential in ventricular myocytes exposed to anoxia-reoxygenation. Am J Physiol 275, H484-494 (1998)
198. Jovanovic N, S Jovanovic, A Jovanovic, and A Terzic: Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress. Faseb J 13, 923-929 (1999)
199. Holmuhamedov EL, L Wang, and A Terzic: ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol 519 Pt 2, 347-360 (1999)
200. Lee TM, SF Su, CC Tsai, YT Lee, and CH Tsai: Cardioprotective effects of 17 beta-estradiol produced by activation ofmitochondrial ATP-sensitive K(+)Channels in canine hearts. J Mol Cell Cardiol 32, 1147-1158 (2000)
201. Tsai CH, SF Su, TF Chou, and TM Lee: Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts. J Pharmacol Exp Ther 301, 234-240 (2002)
202. Lee TM, TF Chou, and CH Tsai: Differential role of K(ATP) channels activated by conjugated estrogens in the regulation of myocardial and coronary protective effects. Circulation 107, 49-54 (2003)
203. Ling S, A Dai, MR Williams, K Myles, RJ Dilley, PA Komesaroff, and K Sudhir: Testosterone (T) enhances apoptosis-related damage in human vascular endothelial cells. Endocrinology 143, 1119-1125 (2002)
204. Verzola D, MT Gandolfo, F Salvatore, B Villaggio, F Gianiorio, P Traverse, G Deferrari, and G Garibotto: Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int 65, 1252-1261 (2004)
205. Zaugg M, NZ Jamali, E Lucchinetti, W Xu, M Alam, SA Shafiq, and MA Siddiqui: Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes. J Cell Physiol 187, 90-95 (2001)
206. Pelzer T, M Schumann, M Neumann, T deJager, M Stimpel, E Serfling, and L Neyses: 17beta-estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Commun 268, 192-200 (2000)
207. Camper-Kirby D, S Welch, A Walker, I Shiraishi, KD Setchell, E Schaefer, J Kajstura, P Anversa, and MA Sussman: Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 88, 1020-1027 (2001)
208. Fujio Y, T Nguyen, D Wencker, RN Kitsis, and K Walsh: Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660-667 (2000)
209. Matsui T, L Li, F del Monte, Y Fukui, TF Franke, RJ Hajjar, and A Rosenzweig: Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100, 2373-2379 (1999)
210. Dudek H, SR Datta, TF Franke, MJ Birnbaum, R Yao, GM Cooper, RA Segal, DR Kaplan, and ME Greenberg: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665 (1997)
211. Datta SR, H Dudek, X Tao, S Masters, H Fu, Y Gotoh, and ME Greenberg: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (1997)
212. Cardone MH, N Roy, HR Stennicke, GS Salvesen, TF Franke, E Stanbridge, S Frisch, and JC Reed: Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321 (1998)
213. Brunet A, A Bonni, MJ Zigmond, MZ Lin, P Juo, LS Hu, MJ Anderson, KC Arden, J Blenis, and ME Greenberg: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999)
214. Suzuki K, B Murtuza, RT Smolenski, IA Sammut, N Suzuki, Y Kaneda, and MH Yacoub: Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 104, I308-I303 (2001)
215. Gwechenberger M, LH Mendoza, KA Youker, NG Frangogiannis, CW Smith, LH Michael, and ML Entman: Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99, 546-551 (1999)
216. Daftarian PM, A Kumar, M Kryworuchko, and F Diaz-Mitoma: IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J Immunol 157, 12-20 (1996)
217. Fiorentino DF, A Zlotnik, TR Mosmann, M Howard, and A O'Garra: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147, 3815-3822 (1991)
218. Mosmann TR: Properties and functions of interleukin-10. Adv Immunol 56, 1-26 (1994)
219. de Waal Malefyt R, J Abrams, B Bennett, CG Figdor, and JE de Vries: Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209-1220 (1991)
220. Salituro FG, UA Germann, KP Wilson, GW Bemis, T Fox, and MS Su: Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases. Curr Med Chem 6, 807-823 (1999)
221. Liao P, SQ Wang, S Wang, M Zheng, SJ Zhang, H Cheng, Y Wang, and RP Xiao: p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes. Circ Res 90, 190-196 (2002)
222. Dougherty CJ, LA Kubasiak, H Prentice, P Andreka, NH Bishopric, and KA Webster: Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J 362, 561-571 (2002)
223. Pantos C, V Malliopoulou, I Paizis, P Moraitis, I Mourouzis, S Tzeis, E Karamanoli, DD Cokkinos, H Carageorgiou, D Varonos, and DV Cokkinos: Thyroid hormone and cardioprotection: study of p38 MAPK and JNKs during ischaemia and at reperfusion in isolated rat heart. Mol Cell Biochem 242, 173-180 (2003)
224. Anwar A, AA Zahid, KJ Scheidegger, M Brink, and P Delafontaine: Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 105, 1220-1225 (2002)
225. Tsai BM, M Wang, M Clauss, P Sun, and DR Meldrum: Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine. Am J Physiol Regul Integr Comp Physiol 287, R767-771 (2004)
226. Peng T, X Lu, M Lei, and Q Feng: Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor-alpha expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes. J Biol Chem 278, 8099-8105 (2003)
227. Song X, G Li, J Vaage, and G Valen: Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 177, 459-466 (2003)
228. Cavasin MA, SS Sankey, AL Yu, S Menon, and XP Yang: Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284, H1560-1569 (2003)
229. Krieg M, K Smith, and W Bartsch: Demonstration of a specific androgen receptor in rat heart muscle: relationship between binding, metabolism, and tissue levels of androgens. Endocrinology 103, 1686-1694 (1978)
230. Marsh JD, MH Lehmann, RH Ritchie, JK Gwathmey, GE Green, and RJ Schiebinger: Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98, 256-261 (1998)
231. Wehling M: Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59, 365-393 (1997)
232. Chou TM, K Sudhir, SJ Hutchison, E Ko, TM Amidon, P Collins, and K Chatterjee: Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94, 2614-2619 (1996)
233. Yue P, K Chatterjee, C Beale, PA Poole-Wilson, and P Collins: Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91, 1154-1160 (1995)
234. Welder AA, JW Robertson, RD Fugate, and RB Melchert: Anabolic-androgenic steroid-induced toxicity in primary neonatal rat myocardial cell cultures. Toxicol Appl Pharmacol 133, 328-342 (1995)
235. Remmers DE, WG Cioffi, KI Bland, P Wang, MK Angele, and IH Chaudry: Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg 227, 790-799 (1998)
236. Barkett M, D Xue, HR Horvitz, and TD Gilmore: Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J Biol Chem 272, 29419-29422 (1997)
237. Ghayur T, S Banerjee, M Hugunin, D Butler, L Herzog, A Carter, L Quintal, L Sekut, R Talanian, M Paskind, W Wong, R Kamen, D Tracey, and H Allen: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386, 619-623 (1997)
238. Ramage P, D Cheneval, M Chvei, P Graff, R Hemmig, R Heng, HP Kocher, A Mackenzie, K Memmert, L Revesz, and et al: Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor. J Biol Chem 270, 9378-9383 (1995)
239. Dinarello CA and BJ Pomerantz: Proinflammatory cytokines in heart disease. Blood Purif 19, 314-321 (2001)
240. Miyawaki H, Y Wang, and M Ashraf: Oxidant stress with hydrogen peroxide attenuates calcium paradox injury: role of protein kinase C and ATP-sensitive potassium channel. Cardiovasc Res 37, 691-699 (1998)
241. Kang SJ, S Wang, H Hara, EP Peterson, S Namura, S Amin-Hanjani, Z Huang, A Srinivasan, KJ Tomaselli, NA Thornberry, MA Moskowitz, and J Yuan: Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 149, 613-622 (2000)
242. Guerra S, A Leri, X Wang, N Finato, C Di Loreto, CA Beltrami, J Kajstura, and P Anversa: Myocyte death in the failing human heart is gender dependent. Circ Res 85, 856-866 (1999)
243. Konopleva M, S Zhao, Z Xie, H Segall, A Younes, DF Claxton, Z Estrov, SM Kornblau, and M Andreeff: Apoptosis. Molecules and mechanisms. Adv Exp Med Biol 457, 217-236 (1999)
244. Vanden Hoek TL, Y Qin, K Wojcik, CQ Li, ZH Shao, T Anderson, LB Becker, and KJ Hamann: Reperfusion, not simulated ischemia, initiates intrinsic apoptosis injury in chick cardiomyocytes. Am J Physiol Heart Circ Physiol 284, H141-150 (2003)
245. O'Mahoney ME, S Logue, E Szegezdi, C Stenson-Cox, U Fitzgerald, and A Samali: Hypoxia and ischemia induce nuclear condensation and caspase activation in cardiomyocytes. Ann N Y Acad Sci 1010, 728-732 (2003)
246. Dickerman RD, F Schaller, I Prather, and WJ McConathy: Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86, 172-173 (1995)
247. Abu-Shakra S, MS Alhalabi, FC Nachtman, RA Schemidt, and WS Brusilow: Anabolic steroids induce injury and apoptosis of differentiated skeletal muscle. J Neurosci Res 47, 186-197 (1997)
248. Grady D, W Applegate, T Bush, C Furberg, B Riggs, and SB Hulley: Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials 19, 314-335 (1998)
249. Grady D, NK Wenger, D Herrington, S Khan, C Furberg, D Hunninghake, E Vittinghoff, and S Hulley: Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 132, 689-696 (2000)
250. Hodis HN, WJ Mack, RA Lobo, D Shoupe, A Sevanian, PR Mahrer, RH Selzer, CR Liu Cr, CH Liu Ch, and SP Azen: Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 135, 939-953 (2001)
251. Grodstein F, JE Manson, and MJ Stampfer: Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study. Ann Intern Med 135, 1-8 (2001)
252. Heckbert SR, RC Kaplan, NS Weiss, BM Psaty, D Lin, CD Furberg, JR Starr, GD Anderson, and AZ LaCroix: Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. Arch Intern Med 161, 1709-1713 (2001)
253. Alexander KP, LK Newby, AS Hellkamp, RA Harrington, ED Peterson, S Kopecky, A Langer, P O'Gara, CM O'Connor, RN Daly, RM Califf, S Khan, and V Fuster: Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol 38, 1-7 (2001)
254. Collins P: Clinical cardiovascular studies of hormone replacement therapy. Am J Cardiol 90, 30F-34F (2002)
255. Canner PL and M Halperin: Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group. Circulation 63, 1342-1350 (1981)
256. Castellsague J, S Perez Gutthann, and LA Garcia Rodriguez: Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review. Drug Saf 18, 117-123 (1998)
257. Kawano H, T Motoyama, N Hirai, T Yoshimura, K Kugiyama, H Ogawa, H Okamura, and H Yasue: Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am J Cardiol 87, 238-240, A239 (2001)
258. Miyagawa K, J Rosch, F Stanczyk, and K Hermsmeyer: Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med 3, 324-327 (1997)
259. Williams JK, EK Honore, SA Washburn, and TB Clarkson: Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 24, 1757-1761 (1994)
260. rd: Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 36, 1797-1802 (2000)
261. Hodis HN and WJ Mack: Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 89, 19E-27E; discussion 27E (2002)
262. Dollar AL, AH Kragel, DJ Fernicola, MA Waclawiw, and WC Roberts: Composition of atherosclerotic plaques in coronary arteries in women less than 40 years of age with fatal coronary artery disease and implications for plaque reversibility. Am J Cardiol 67, 1223-1227 (1991)
263. Losordo DW, M Kearney, EA Kim, J Jekanowski, and JM Isner: Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89, 1501-1510 (1994)
264. Walsh BW, I Schiff, B Rosner, L Greenberg, V Ravnikar, and FM Sacks: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325, 1196-1204 (1991)
265. Nabulsi AA, AR Folsom, A White, W Patsch, G Heiss, KK Wu, and M Szklo: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med 328, 1069-1075 (1993)
266. Fischer GM and ML Swain: Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 54, 177-185 (1985)
267. Godsland IF, K Gangar, C Walton, MP Cust, MI Whitehead, V Wynn, and JC Stevenson: Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42, 846-853 (1993)
268. Haarbo J, U Marslew, A Gotfredsen, and C Christiansen: Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40, 1323-1326 (1991)
269. Stampfer MJ and GA Colditz: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20, 47-63 (1991)
270. Ridker PM, CH Hennekens, JE Buring, and N Rifai: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342, 836-843 (2000)
271. Fisher B, J Costantino, C Redmond, R Poisson, D Bowman, J Couture, NV Dimitrov, N Wolmark, DL Wickerham, ER Fisher, and et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive rumors. N Engl J Med 320, 479-484 (1989)
272. Dai-Do D, E Espinosa, G Liu, TJ Rabelink, F Julmy, Z Yang, F Mahler, and TF Luscher: 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovasc Res 32, 980-985 (1996)
273. Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 339, 1609-1618 (1998)
274. rd: Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women. Am J Cardiol 76, 1072-1073 (1995)
275. Walsh BW, LH Kuller, RA Wild, S Paul, M Farmer, JB Lawrence, AS Shah, and PW Anderson: Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. Jama 279, 1445-1451 (1998)
276. Anzano MA, CW Peer, JM Smith, LT Mullen, MW Shrader, DL Logsdon, CL Driver, CC Brown, AB Roberts, and MB Sporn: Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. J Natl Cancer Inst 88, 123-125 (1996)
277. Nozaki M, R Ogata, K Koera, K Hashimoto, and H Nakano: Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy. Climacteric 2, 124-130 (1999)
278. rd: Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women. Thromb Haemost 82, 626-633 (1999)
279. Meade TW, AP Haines, JD Imeson, Y Stirling, and SG Thompson: Menopausal status and haemostatic variables. Lancet 1, 22-24 (1983)
280. Scarabin PY, C Bonithon-Kopp, L Bara, A Malmejac, L Guize, and M Samama: Factor VII activation and menopausal status. Thromb Res 57, 227-234 (1990)
281. Folsom AR, KK Wu, CE Davis, MG Conlan, PD Sorlie, and M Szklo: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91, 191-205 (1991)
282. Barrett-Connor E, S Slone, G Greendale, D Kritz-Silverstein, M Espeland, SR Johnson, M Waclawiw, and SE Fineberg: The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women. Maturitas 27, 261-274 (1997)
283. McPherson R: Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study. Can J Cardiol 16 Suppl A, 14A-19A (2000)
284. Cushman M: Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation. Am J Cardiol 90, 7F-10F (2002)
285. Cushman M, C Legault, E Barrett-Connor, ML Stefanick, C Kessler, HL Judd, PA Sakkinen, and RP Tracy: Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 100, 717-722 (1999)
286. rd: Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med 336, 683-690 (1997)
287. Oian P and B Osterud: Monocyte-platelet function and protection against cardiovascular disease. Maturitas 23 Suppl, S57-60 (1996)
288. Mammen EF: Oral contraceptives and blood coagulation: a critical review. Am J Obstet Gynecol 142, 781-790 (1982)
289. Aune B, P Oian, I Omsjo, and B Osterud: Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - a beneficial effect on atherogenesis and thrombus formation? Am J Obstet Gynecol 173, 1816-1820 (1995)
290. Gebara OC, MA Mittleman, P Sutherland, I Lipinska, T Matheney, P Xu, FK Welty, PW Wilson, D Levy, JE Muller, and et al: Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 91, 1952-1958 (1995)
291. Kroon UB, G Silfverstolpe, and L Tengborn: The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost 71, 420-423 (1994)
292. Gilabert J, A Estelles, A Cano, F Espana, R Barrachina, S Grancha, J Aznar, and M Tortajada: The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status. Am J Obstet Gynecol 173, 1849-1854 (1995)
293. Kooistra T: The use of cultured human endothelial cells and hepatocytes as an in vitro model system to study modulation of endogenous fibrinolysis. Fibrinolysis 4, 33-39 (1990)
294. van Kesteren PJ, T Kooistra, M Lansink, GJ van Kamp, H Asscheman, LJ Gooren, JJ Emeis, UM Vischer, and CD Stehouwer: The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79, 1029-1033 (1998)
295. Sobel MI, CA Winkel, LB Macy, P Liao, and TD Bjornsson: The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obstet Gynecol 173, 801-808 (1995)
296. Caine YG, KA Bauer, S Barzegar, H ten Cate, FM Sacks, BW Walsh, I Schiff, and RD Rosenberg: Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost 68, 392-395 (1992)
297. Scarabin PY, M Alhenc-Gelas, G Plu-Bureau, P Taisne, R Agher, and M Aiach: Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 17, 3071-3078 (1997)
298. Chandler WL, SL Trimble, SC Loo, and D Mornin: Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood 76, 930-937 (1990)
299. Selzman CH, JS Gaynor, AS Turner, TA Whitehill, LD Horwitz, and AH Harken: Estrogen replacement inhibits intimai hyperplasia and the accumulation and effects of transforming growth factor beta1. J Surg Res 80, 380-385 (1998)
300. Selzman CH, SA Miller, and AH Harken: Therapeutic implications of inflammation in atherosclerotic cardiovascular disease. Ann Thorac Surg 71, 2066-2074 (2001)
301. Weusten JJ, MA Blankenstein, FH Gmelig-Meyling, HJ Schuurman, L Kater, and JH Thijssen: Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol (Copenh) 112, 409-414 (1986)
302. Cannon JG and CA Dinarello: Increased plasma interleukin-1 activity in women after ovulation. Science 227, 1247-1249 (1985)
303. Kassem M, S Khosla, TC Spelsberg, and BL Riggs: Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab 81, 513-518 (1996)
304. Pacifici R, C Brown, E Puscheck, E Friedrich, E Slatopolsky, D Maggio, R McCracken, and LV Avioli: Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A 88, 5134-5138 (1991)
305. Polan ML, J Loukides, P Nelson, S Carding, M Diamond, A Walsh, and K Bottomly: Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 69, 1200-1206 (1989)
306. Biswas P, F Delfanti, S Bernasconi, M Mengozzi, M Cota, N Polentarutti, A Mantovani, A Lazzarin, S Sozzani, and G Poli: Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91, 258-265 (1998)
307. Sukovich DA, K Kauser, FD Shirley, V DelVecchio, M Halks-Miller, and GM Rubanyi: Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol. Arterioscler Thromb Vasc Biol 18, 1498-1505 (1998)
308. Zang YC, JB Halder, J Hong, VM Rivera, and JZ Zhang: Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol 124, 106-114 (2002)
309. Selzman CH, BD Shames, LL Reznikov, SA Miller, X Meng, HA Barton, A Werman, AH Harken, CA Dinarello, and A Banerjee: Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. Circ Res 84, 867-875 (1999)
310. Libby P: Molecular bases of the acute coronary syndromes. Circulation 91, 2844-2850 (1995)
311. Cannon RO, 3rd, BK Yang, and J Ardans: Increased serum matrix levels of metalloproteinase-9 expression in postmenopausal women on estrogen therapy. J Am Coll Cardiol 35, 303 (1995)
312. Zhang X, L Wang, H Zhang, D Guo, Z Qiao, and J Qiao: Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages. Methods Find Exp Clin Pharmacol 23, 169-173 (2001)
313. Kamada M, M Irahara, M Maegawa, Y Ohmoto, T Takeji, T Yasui, and T Aono: Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 184, 309-314 (2001)
314. Fisher B, JP Costantino, DL Wickerham, CK Redmond, M Kavanah, WM Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins, M Daly, S Wieand, E Tan-Chiu, L Ford, and N Wolmark: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90, 1371-1388 (1998)
315. Friend KE, ML Hartman, SS Pezzoli, JL Clasey, and MO Thorner: Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - a clinical research center study. J Clin Endocrinol Metab 81, 2250-2256 (1996)
316. Saito S, N Motomura, H Lou, PW Ramwell, and ML Foegh: Specific effects of estrogen on growth factor and major histocompatibility complex class II antigen expression in rat aortic allograft. J Thorac Cardiovasc Surg 114, 803-809; discussion 809-810 (1997)
317. Shanker G, M Sorci-Thomas, and MR Adams: Estrogen modulates the inducible expression of platelet-derived growth factor mRNA by monocyte/macrophages. Life Sci 56, 499-507 (1995)
318. Auwerx J: The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47, 22-31 (1991)
319. Koyama N, N Morisaki, Y Saito, and S Yoshida: Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 267, 22806-22812 (1992)
320. Kolodgie FD, A Jacob, PS Wilson, GC Carlson, A Farb, A Verma, and R Virmani: Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol 148, 969-976 (1996)
321. Kikuchi N, M Urabe, K Iwasa, T Okubo, H Tsuchiya, T Hosoda, H Tatsumi, and H Honjo: Atheroprotective effect of estriol and estrone sulfate on human vascular smooth muscle cells. J Steroid Biochem Mol Biol 72, 71-78 (2000)
322. Somjen D, F Kohen, A Jaffe, Y Amir-Zaltsman, E Knoll, and N Stern: Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 32, 39-45 (1998)
323. Ridker PM, MJ Stampfer, and N Rifai: Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Jama 285, 2481-2485 (2001)
324. Pasceri V, JT Willerson, and ET Yeh: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102, 2165-2168 (2000)
325. Cermak J, NS Key, RR Bach, J Balla, HS Jacob, and GM Vercellotti: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82, 513-520 (1993)
326. Ridker PM, CH Hennekens, N Rifai, JE Buring, and JE Manson: Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100, 713-716 (1999)
327. Baumann H and J Gauldie: The acute phase response. Immunol Today 15, 74-80 (1994)
328. Walsh BW, DA Cox, A Sashegyi, RA Dean, RP Tracy, and PW Anderson: Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women. Am J Cardiol 88, 825-828 (2001)
329. Caulin-Glaser T, CA Watson, R Pardi, and JR Bender: Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98, 36-42 (1996)
330. Caulin-Glaser T, WJ Farrell, SE Pfau, B Zaret, K Bunger, JF Setaro, JJ Brennan, JR Bender, MW Cleman, HS Cabin, and MS Remetz: Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J Am Coll Cardiol 31, 1555-1560 (1998)
331. Van Baal WM, JJ Emeis, P Kenemans, H Kessel, ER Peters-Muller, CG Schalkwijk, MJ van der Mooren, and CD Stehouwer: Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 29, 913-921 (1999)
332. Seljeflot I, H Arnesen, AE Hofstad, and I Os: Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease. Thromb Haemost 83, 944-948 (2000)
333. Oger E, M Alhenc-Gelas, G Plu-Bureau, L Mennen, M Cambillau, L Guize, Y Pujol, and P Scarabin: Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users. Thromb Res 101, 35-43 (2001)
334. Mikkola TS and RW St Clair: Estradiol reduces basal and cytokine induced monocyte adhesion to endothelial cells. Maturitas 41, 313-319 (2002)
335. Christodoulakos G, C Panoulis, E Kouskouni, C Chondros, S Dendrinos, and G Creatsas: Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis. Gynecol Endocrinol 16, 9-17 (2002)
336. Cain BS, DR Meldrum, CH Selzman, JC Cleveland, Jr., X Meng, BC Sheridan, A Banerjee, and AH Harken: Surgical implications of vascular endothelial physiology. Surgery 122, 516-526 (1997)
337. Spyridopoulos I, AB Sullivan, M Kearney, JM Isner, and DW Losordo: Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95, 1505-1514 (1997)
338. Steinleitner A, FZ Stanczyk, JH Levin, G d'Ablaing, 3rd, MA Vijod, VL Shahbazian, and RA Lobo: Decreased in vitro production of 6-keto-prostaglandin F1 alpha by uterine arteries from postmenopausal women. Am J Obstet Gynecol 161, 1677-1681 (1989)
339. Mikkola T, P Turunen, K Avela, A Orpana, L Viinikka, and O Ylikorkala: 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 80, 1832-1836 (1995)
340. O'Sullivan MG, JA Goodrich, and MR Adams: Increased prostacyclin synthesis by atherosclerotic arteries from estrogen-treated monkeys. Life Sci 69, 395-401 (2001)
341. Ospina JA, DN Krause, and SP Duckles: 17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33, 600-605 (2002)
342. Sherman TS, KL Chambliss, LL Gibson, MC Pace, ME Mendelsohn, SL Pfister, and PW Shaul: Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol 26, 610-616 (2002)
343. Redmond EM, MN Cherian, and RC Wetzel: 17 beta-Estradiol inhibits flow- and acute hypoxia-induced prostacyclin release from perfused endocardial endothelial cells. Circulation 90, 2519-2524 (1994)
344. Saitta A, D Altavilla, D Cucinotta, N Morabito, N Frisina, F Corrado, R D'Anna, A Lasco, G Squadrito, A Gaudio, F Cancellieri, V Arcoraci, and F Squadrito: Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 21, 1512-1519 (2001)
345. Che W, N Lerner-Marmarosh, Q Huang, M Osawa, S Ohta, M Yoshizumi, M Glassman, JD Lee, C Yan, BC Berk, and J Abe: Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90, 1222-1230 (2002)
346. Jhund PS, N Dawson, AP Davie, N Sattar, J Norrie, KP O'Kane, and JJ McMurray: Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. J Am Coll Cardiol 37, 1367-1373 (2001)
347. Ishizuka T, M Takamizawa-Matsumoto, K Suzuki, and A Kurita: Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells. Eur J Pharmacol 369, 237-245 (1999)
348. Saito S, RS Aras, H Lou, PW Ramwell, and ML Foegh: Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells. J Heart Lung Transplant 18, 937-945 (1999)
349. Wagner AH, MR Schroeter, and M Hecker: 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. Faseb J 15, 2121-2130 (2001)
350. Duncan AC, JR Petrie, MJ Brosnan, AM Devlin, RA Bass, DS Charnock-Jones, JM Connell, AF Dominiczak, and MA Lumsden: Is estradiol cardioprotection a nitric oxide-mediated effect? Hum Reprod 17, 1918-1924 (2002)
351. Gisclard V, VM Miller, and PM Vanhoutte: Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244, 19-22 (1988)
352. Williams JK, MR Adams, DM Herrington, and TB Clarkson: Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 20, 452-457 (1992)
353. Collins P, GM Rosano, PM Sarrel, L Ulrich, S Adamopoulos, CM Beale, JG McNeill, and PA Poole-Wilson: 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92, 24-30 (1995)
354. Reis SE, ST Gloth, RS Blumenthal, JR Resar, HA Zacur, G Gerstenblith, and JA Brinker: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89, 52-60 (1994)
355. Yang SH, J Shi, AL Day, and JW Simpkins: Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31, 745-749; discussion 749-750 (2000)
356. Toung TJ, RJ Traystman, and PD Hurn: Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29, 1666-1670 (1998)
357. Simpkins JW, G Rajakumar, YQ Zhang, CE Simpkins, D Greenwald, CJ Yu, N Bodor, and AL Day: Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87, 724-730 (1997)
358. Nonaka A, J Kiryu, A Tsujikawa, K Yamashiro, K Miyamoto, H Nishiwaki, M Mandai, Y Honda, and Y Ogura: Administration of 17beta-estradiol attenuates retinal ischemia-reperfusion injury in rats. Invest Ophthalmol Vis Sci 41, 2689-2696 (2000)
359. Squadrito F, D Altavilla, G Squadrito, GM Campo, M Arlotta, V Arcoraci, L Minutoli, A Saitta, and AP Caputi: The involvement of tumour necrosis factor-alpha in the protective effects of 17 beta oestradiol in splanchnic ischaemia-reperfusion injury. Br J Pharmacol 121, 1782-1788 (1997)
360. Zhai P, TE Eurell, PS Cooke, DB Lubahn, and DR Gross: Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am J Physiol Heart Circ Physiol 278, H1640-1647 (2000)
361. Zhai P, TE Eurell, RP Cotthaus, EH Jeffery, JM Bahr, and DR Gross: Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am J Physiol Heart Circ Physiol 281, H1223-1232 (2001)
362. McNulty PH, D Jagasia, JM Whiting, and T Caulin-Glaser: Effect of 6-wk estrogen withdrawal or replacement on myocardial ischemic tolerance in rats. Am J Physiol Heart Circ Physiol 278, H1030-1034 (2000)
363. Benjamin IJ and E Christians: Exercise, estrogen, and ischemic cardioprotection by heat shock protein 70. Circ Res 90, 833-835 (2002)
364. Benjamin IJ and DR McMillan: Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. Circ Res 83, 117-132 (1998)
365. Dillmann WH: Small heat shock proteins and protection against injury. Ann N Y Acad Sci 874, 66-68 (1999)
366. Karmazyn M, K Mailer, and RW Currie: Acquisition and decay of heat-shock-enhanced postischemic ventricular recovery. Am J Physiol 259, H424-431 (1990)
367. Paroo Z, JV Haist, M Karmazyn, and EG Noble: Exercise improves postischemic cardiac function in males but not females: consequences of a novel sex-specific heat shock protein 70 response. Circ Res 90, 911-917 (2002)
368. Vaccarino V, TR Holford, and HM Krumholz: Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36, 130-138 (2000)
369. Hayward CS, CM Webb, and P Collins: Hormone replacement therapy and heart-rate variability. Lancet 354, 256 (1999)
370. McCredie RJ, JA McCrohon, L Turner, KA Griffiths, DJ Handelsman, and DS Celermajer: Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol 32, 1331-1335 (1998)
371. McCrohon JA, W Jessup, DJ Handelsman, and DS Celermajer: Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99, 2317-2322 (1999)
372. Mukherjee TK, H Dinh, G Chaudhuri, and L Nathan: Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci U S A 99, 4055-4060 (2002)
373. Ayashi A, R Mathur, and P Halushka: Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 91, 2742-2747 (1995)